|
|
|
| home > news > detailed info |
|
|
 INDUSTRY NEWS AND PRESS RELEASES |
High performance range of insulated shipping systems |
 |
|
Laminar Medica’s Chilltherm® Global range of high performance insulated shipping systems, from 4 to 1130 litres product volume, are designed to offer optimal thermal protection for pharmaceutical products when exposed to extreme climates from -20°C to +40°C.
These shipping systems are pre-qualified to maintain payload integrity between +2°C and +8°C for transit durations of up to 120 hours. Real live data profiles have been used to give customers confidence that the quality and efficacy of their payloads will not be compromised during even the most demanding external temperatures. Cross hemisphere profile testing makes it ideal for clients making transcontinental shipments.
With only three sizes of cool packs used across the range and a common bill of materials for summer and winter pack outs the impact to warehousing and handling is minimised. |
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Almac wins Laboratory Team of the Year at The Irish Laboratory Awards 2013
The awards, the first of their kind in Ireland, were held to recognise the success and achievements of Ireland’s internationally renowned scientists in areas including innovation, leadership and collaboration, and focus on the on-going work of Irish scientists to grow and develop sustainable, globally competitive science research.
More info >> |
|
 |
White Papers |
 |
|
The Flexible Factory Concept: A flexible bioprocessing platform to meet the changing needs of biomanufacturing
GE Healthcare Life Sciences
For the past several years, the biopharma industry has been buffeted by
dynamic market conditions that are rapidly reshaping manufacturing
requirements. These factors include:
• The rise of small-market pharmaceuticals that do not require the production scale of the previous “blockbuster” drug model
• Increased titers and process productivity that generate more bulk-product within a much smaller manufacturing footprint
• The emergence of biosimilars and continued evolution of healthcare
reform, which will increasingly pressure drug pricing and require
greater cost discipline
• Greater competition and shorter patent protection timelines, which will further ratchet up time-to-market pressures
• Tighter capital markets that will create heightened scrutiny for all new investment projects
More info >> |
|
 |
Industry Events |
 |
Advances and Progress in Drug Design
17-18 February 2014, Marriott Regents Park Hotel, London, UK
SMi are proud to present the 13th annual Advances and Progress in Drug
Design conference, convening in Central London on Monday 17 and Tuesday 18 February 2014. This exciting event will
focus on new approaches and will offer attendees the chance to hear from
leading industry experts on lead optimisation strategies, SBDD and FBDD.
More info >> |
|
|
